FinThrive Named 2025 Best in KLAS for Insurance Discovery for the Third Consecutive Year
FinThrive Insurance Discover™ leads the market with an overall score of 91.6 PLANO, Texas, Feb. 5, 2025 /PRNewswire/ -- FinThrive,...
Month: February 2025
Lifesum Transforms Meal Tracking with AI-Powered Multimodal Tracker for Personalized Nutrition
LOS ANGELES, Feb. 5, 2025 /PRNewswire/ -- Lifesum, the leading global healthy eating app, has transformed meal tracking with an...
Findhelp Ranked #1 “Best in KLAS” Social Determinants of Health Network for Fourth Consecutive Year
AUSTIN, Texas, Feb. 5, 2025 /PRNewswire/ -- KLAS Research's 2025 Best in KLAS - Software and Services report has named...
Waystar recognized as the leading healthcare software platform with top marks for client satisfaction
Receives multiple Best in KLAS awards in Claims Management & Clearinghouse and Patient Access LEHI, Utah and LOUISVILLE, Ky., Feb. 5,...
Jones Healthcare Group Earns Top Honour for Packaging Innovation at PAC Global Awards
FlexRx(TM) One Medication Adherence Packaging Wins Best of Show for Package Innovation Design and Recognition for Carbon ReductionLondon, Ontario--(Newsfile Corp....
New Functional Medicine Practice, Aura Functional Medicine, Offers Holistic, Root-Cause Focused Healthcare to the Boulder, Colorado Area
Functional medicine expert and naturopathic doctor, Dr. Alison Egeland, has launched Aura Functional Medicine, a new practice that applies the...
Nuvectis Pharma Announces Pricing of $13.5 Million Public Offering of Common Stock
FORT LEE, N.J., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical-stage biopharmaceutical company focused on...
Arbor Biotechnologies Announces FDA Orphan Drug and Rare Pediatric Disease Designations Granted to ABO-101 for the Treatment of Primary Hyperoxaluria Type 1 (PH1) and Upcoming Presentations at the 20th Congress of the International Pediatric Nephrology Association (IPNA)
Orphan Drug and Rare Pediatric Disease designations follow U.S. FDA acceptance of IND application for ABO-101 for the treatment of...
New Survey from Aeroflow Urology Reveals Lack of Postpartum Incontinence Care Causes Lasting Health Problems for Mothers
Despite 85% of mothers experiencing frequent bladder leaks during postpartum, the survey found only 15% of mothers received resources and...
Counterpart Health Signs Multi-Year Agreement with Southern Illinois Healthcare
WILMINGTON, Del., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), an AI-powered physician enablement platform, today announced a...
AMN Healthcare’s Smart Square® Recognized as 2025 Highest Ranked Workforce Solution in Latest KLAS Report
DALLAS, Feb. 05, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare, the leader and innovator in total talent solutions for healthcare organizations,...
Myriad Genetics and Lumea Collaborate to Enhance Access to the Prolaris Biomarker and MyRisk Hereditary Cancer Tests through BxLink Integration
SALT LAKE CITY, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic...
Gain Therapeutics To Participate in Upcoming Investor Conferences
BETHESDA, Md., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology...
Lisata Therapeutics to Present at the 2025 BIO CEO & Investor Conference
BASKING RIDGE, N.J., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage...
Creative Medical Technology Holdings Expands Collaboration with Greenstone Biosciences to Accelerate iPSCelz Pipeline Development
PHOENIX, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical”), a clinical-stage biotechnology company...
Oragenics, Inc. Chief Medical Officer, Dr. James P. Kelly, to Participate in the 12th Annual Brain Health Summit at the Leigh Steinberg Super Bowl Party 2025
SARASOTA, Fla., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company advancing innovative treatments for...
A Race Against Blindness Announces $2 Million Grant to Support Sight-Saving Clinical Trial
PHOENIX, Feb. 05, 2025 (GLOBE NEWSWIRE) -- A Race Against Blindness, a nonprofit organization dedicated to funding sight-saving therapies for...
Cellectar Biosciences to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
FLORHAM PARK, N.J., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused...
Orchestra BioMed Announces Appointment of Former Medtronic SVP of Corporate Development Christopher Cleary to Board of Directors
Medical device industry veteran brings over three decades of expertise in M&A, as well as structured research and development (“R&D”)...
Ultragenyx Announces New Data Demonstrating that Treatment with UX111 AAV Gene Therapy Significantly Improved Clinical Function Across Multiple Developmental Domains in Children with Sanfilippo Syndrome Type A (MPS IIIA) Correlated with Sustained Reductions in CSF-HS
Modified intent-to-treat group demonstrated +22.7 point (p<0.0001) treatment effect in the mean Bayley-III cognitive raw score compared to natural history...